LGR5 inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

No biomarker	Squamous Cell Carcinoma of Head and Neck	No biomarker	Squamous Cell Carcinoma of Head and Neck	MCLA-158 Sensitive: B - Late Trials MCLA-158 Sensitive : B	MCLA-158 Sensitive: B - Late Trials MCLA-158 Sensitive : B
KRAS mutation	Colorectal Cancer	KRAS mutation	Colorectal Cancer	MCLA-158 Sensitive: D – Preclinical MCLA-158 Sensitive : D	MCLA-158 Sensitive: D – Preclinical MCLA-158 Sensitive : D

Associations(2)